Skip to main content
OncoTargets and Therapy logoLink to OncoTargets and Therapy
. 2022 Jun 15;15:681–682. doi: 10.2147/OTT.S378352

LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction]

PMCID: PMC9207122  PMID: 35733651

Bi H, Shang Z, Jia C, et al. Onco Targets Ther. 2020;13:11277–11288.

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised following the authors request to replace duplicated images in Figure 2E and 2F and Figure 5F and 5G. Specifically,

  • Figure 2E, J82 si-NC appears to have been duplicated with Figure 2E, 5637 si-NC and Figure 2F, J82 si-NC.

  • Figure 2E, J82 si-RNF144A-AS1 appears to have been duplicated with Figure 2E, 5637 si-RNF144A-AS1 and Figure 2F, J82 si-RNF144A-AS1.

  • Figure 5F, J82 si-NC appears to have been duplicated with Figure 5F, 5637 si-RNF144A-AS1+OE SOX11.

  • Figure 5F, J82 si-RNF144A-AS1 appears to have been duplicated Figure 5F, 5637 si-RNF144A-AS1.

  • Figure 5G, J82 si-NC appears to have been duplicated with Figure 5G, J82 si-RNF144A-AS1+OE SOX11 and Figure 5G, 5637 si-NC.

  • Figure 5G, J82 si-RNF144A-AS1 appears to have been duplicated with Figure 5G, 5637 si-RNF144A-AS1.

The authors responded to our queries but could not provide a satisfactory explanation for the number of duplicated images that occurred. The authors also provided some original data, but this was not satisfactory and was unable to verify the reported findings. The decision was made to retract the article and the authors were notified of this.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


Articles from OncoTargets and therapy are provided here courtesy of Dove Press

RESOURCES